Lipid profile in children with insulin dependent diabetes mellitus

Journal of the Pakistan Medical Association

Volumn 52, Issue 1, 2002, Pages 29-34

  Al Naama, L M ^a   Kadhim, M ^a   Al Aboud, M S ^a  

^a UNIVERSITY OF BASRAH   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CHILD; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE;

ANALYSIS OF VARIANCE; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHILD; CHOLESTEROL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; TRIGLYCERIDES;

EID: 0036360062     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Report of a WHO Study Group. Prevention of diabetes mellitus. WHO Technical Report Series No. 844. Geneva. 1994.
2. Sperling MA. Diabetes mellitus. In: Nelson's "Textbook of pediatrics Nelson WE, Behrman RE, Kliegman RM, Arvin AM. (eds)" 16th ed. Philadelphic: W.B. Saunders Co., 2000, pp.1767-86.
3. Report of a WHO Study Group. Diabetes mellitus. WHO Technical Report Series No. 727. Geneva. 1985, pp.29-31.
4. Kelnar CJ. Endocrine gland disorders and disorders of growth and puberty. In: Forfor & Arneils" textbook of paediatrics. 5th ed. London: Churchill Livingston, 1998, pp.1080.
5. Leslie ND, Sperling MA. Relation of metabolic control to complications of diabetes. J. Paediatr.,1986; 108:491-6.
6. Tamborlane WV, Ahem JA. Implications and results of the diabetes control and complications trial. Pediatr Clin. N. Am., 1997; 44:285-98.
7. Klein R, Klein BEK, Moss SE. Relation of glycemiccontrol to diabetic microvascular complication in diabetes mellitus. Ann. Intern. Med., 1996; 124:90-6.
8. Nathan DM. The pathophysiology of diabetic complications: how much does the glucose hypothesis explain? Ann. Intern. Med., 1996:124:86-9.
9. OhtaT, Nishiyama S, NakamuraT, et al. Predominance of large low density lipoprotein particles and lower fractional esterification rate of cholesterol in high Density lipoprotein in children with insulin dependent diabetes mellitus. Eur. J. Paediatr.,1998; 157: 276-81.
10. Teitz NW. Fundamentals of clinical chemistry. 3rd ed. Philadephia: W.B.Saunders Co., 1996, pp. 448-81.
11. Standefer JC, Eaton RP. Evaluation of a colorimetric method for determination of glycosylated haemoglobin. Clin. Chem., 1983; 29:135-40.
12. Gracia RE, Moodie DS. Routine surveillance in childhood. Paediatr., 1989; 84:751-4.
13. Stanley CA. Defects in metabolism of lipids. In: Nelson Textbook of Paediatrics. 16th ed. Philadelphia: W.B. Saunders Co., 2000, pp.389-90.
14. Maner AM. Commentaries: biochemical, clinical, epidemiologic, genetic and pathologic data in the pediatric age group relevant to the cholesterol hypothesis. Paediatr., 1986; 78:439-70
15. Azad K, Parkin JM, Court S, et al. Circulating lipids and glycemic control in insulin-dependent diabetic children. Arch. Dis. Child., 1994; 71:108-13.
16. Tones-Tamayo M, Zamora-Gonzalelz J, Braro-Riose, et al. Lipoprotein (a) levels in children and adolescents with diabetes. Rev. Invest. Clin., 1997; 49:437-43.
17. Torres-Tamayo M, Lerman-Carber I, Bravo-Rios E, et al. Metabolic control and the prevalence of dyslipidemia in children and adolescents with IDDM. Rev. Invest. Clin., 1993; 45:545-52.
18. Lipman TH, Hayman LL, Fabian CV, et al. Risk factors for cardiovascular disease in children with Type I diabetes. Nurs. Res., 2000; 49:160-66.
19. Diaz-Gomez NM, Domenech-Martinez E, Rodeiguez-Rodeiguez I., et al. Metabolic control, C-peptide and lipids in IDDM. Ann. Esp-paediatr, 1991; 34:276-82.
20. Marfinez MT, Ramos O, Carretero N, et al. Lipoprotein a and other risk factors in children with IDDM and children without diabetes. Diab. Metabol., 1994; 20:454-57.
21. Ginberg HN. Lipoprotein physiology in non-diabetic and diabetic states: relationship to atherosclerosis. Diabetes Care., 1991; 14:839-55.
22. Pollak A, Widhalm K, Havelec L, et al. Glycosylated haemoglobin (HbAlc) and plasma Iipoproteins in juvenile onset diabetes mellitus. Acta. Paediatr. Scand., 1980; 69:475-9.
23. Strobl W, Widhalm K, Schober E, et al. Apolipoproteins and lipoproteins in children with Type I diabetes: relation to glycosylated serum protein and HbAl. Acta. Paediatr. Scand., 1985; 74:966-71.
24. Weald U, Gustafson S, Tuxedo T, et al. Increased high density lipoprotein in diabetic children. Eur. J. Paediatr., 1984; 142:154-6.
25. Hayashibe H, Asayama K, Nakane T, et al. Decreased activity of plasma cholesteryl ester transfer protein in children and adolescents with insulin-dependent diabetes mellitus. Acta. Paediatr., 1999; 88:1067-70.
26. Lopez-Virella MF, Wohiltman HJ, Loadhold CB, et al. Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control. Diabetologia, 1981; 21:216-23.
27. Lopez-VirellaMF, Wohiltman HJ, Mayfield RK, et al. Effect of metabolic control on lipid., lipoprotein and ap olipoprotein levels in 55 insulin dependent diabetic patients. Diabetes, 1984; 32:20-5.
28. . Laakso M. Lipid and lipoproteins: a risk factors for coronary heart disease in non-insulin dependent diabetes mellitus. Am. Med. J., 1996; 28:341-5.
29. Singh ATK, Rainwater DL, Haffiner SM, et al. Effect of diabetes on lipoprotein size. Arterioscler Thromb Vase Biol., 1995; 15:1805-11.
30. Igau B, Lestvel S, Clavey V, et al. Apo B-containing lipoprotein particles in poorly controlled insulin-dependent diabetes. Atherosclerosis, 1996; 120:209-19.